Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06498934

Deep Brain Stimulation of the Dentate Nucleus for Motor Rehabilitation After Stroke

Deep Brain Stimulation of Cerebellar Dentate Nucleus Promotes Upper Limb Motor Function Recovery After Ischemic Stroke: a Randomized, Double-blind, Sham-controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
Beijing Municipal Administration of Hospitals · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if deep brain stimulation of the dentate nucleus (DN-DBS) works to promote chronic post-stroke upper limb motor function in adults. It will also learn about the safety of DN-DBS. The main questions it aims to answer are: Does DN-DBS paired with rehabilitation improve the upper limb motor function of participants more than rehabilitation only? What medical problems do participants have when using DN-DBS for post-stroke rehabilitation? Researchers will compare real DN-DBS+rehabilitation to sham DN-DBS+rehabilitation (electrodes will be implanted, but no electrical current is given) to see if DN-DBS works to promote chronic post-stroke upper limb motor function. Participants will: Undergo unilateral DN-DBS surgery Take real DN-DBS+rehabilitation or sham DN-DBS+rehabilitation as treatment for 6 months Visit the clinic every month during the DN-DBS+rehabilitation (treatment) period for programing, checkups and tests Visit the clinic at Day 1, 30, 90 and 365 after treatment period for checkups and tests

Conditions

Interventions

TypeNameDescription
DEVICEdeep brain stimulationStimulation of the dentate nucleus that is paired with upper limb rehabilitation movements.
OTHERRehabilitationRehabilitation movements to improve upper limb function after stroke

Timeline

Start date
2024-09-01
Primary completion
2026-12-31
Completion
2027-12-31
First posted
2024-07-12
Last updated
2024-07-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06498934. Inclusion in this directory is not an endorsement.